Murashev AN - Search Results

1

Selective targeting of α7 nicotinic acetylcholine receptor by synthetic peptide mimicking loop I of human SLURP-1 provides efficient and prolonged therapy of epidermoid carcinoma in vivo.

Shlepova OV, Shulepko MA, Shipunova VO, Bychkov ML, Kukushkin ID, Chulina IA, Azev VN, Shramova EI, Kazakov VA, Ismailova AM, Palikova YA, Palikov VA, Kalabina EA, Shaykhutdinova EA, Slashcheva GA, Tukhovskaya EA, Dyachenko IA, Murashev AN, Deyev SM, Kirpichnikov MP, Shenkarev ZO, Lyukmanova EN. Shlepova OV, et al. Among authors: murashev an. Front Cell Dev Biol. 2023 Oct 3;11:1256716. doi: 10.3389/fcell.2023.1256716. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37854069 Free PMC article.

2

Genetic locus on mouse chromosome 7 controls elevated heart rate.

Smolock EM, Ilyushkina IA, Ghazalpour A, Gerloff J, Murashev AN, Lusis AJ, Korshunov VA. Smolock EM, et al. Among authors: murashev an. Physiol Genomics. 2012 Jul 3;44(13):689-98. doi: 10.1152/physiolgenomics.00041.2012. Epub 2012 May 15. Physiol Genomics. 2012. PMID: 22589454 Free PMC article.

3

COG1410, a novel apolipoprotein-E mimetic, improves functional and morphological recovery in a rat model of focal brain ischemia.

Tukhovskaya EA, Yukin AY, Khokhlova ON, Murashev AN, Vitek MP. Tukhovskaya EA, et al. Among authors: murashev an. J Neurosci Res. 2009 Feb 15;87(3):677-82. doi: 10.1002/jnr.21874. J Neurosci Res. 2009. PMID: 18803296 Free PMC article.

4

Anti-inflammatory cytokine interleukin-10 increases resistance to brain ischemia through modulation of ischemia-induced intracellular Ca²⁺ response.

Tukhovskaya EA, Turovsky EA, Turovskaya MV, Levin SG, Murashev AN, Zinchenko VP, Godukhin OV. Tukhovskaya EA, et al. Among authors: murashev an. Neurosci Lett. 2014 Jun 13;571:55-60. doi: 10.1016/j.neulet.2014.04.046. Epub 2014 May 4. Neurosci Lett. 2014. PMID: 24796809

5

Autonomic dysfunction determines stress-induced cardiovascular and immune complications in mice.

Batchu SN, Smolock EM, Dyachenko IA, Murashev AN, Korshunov VA. Batchu SN, et al. Among authors: murashev an. J Am Heart Assoc. 2015 May 21;4(5):e001952. doi: 10.1161/JAHA.115.001952. J Am Heart Assoc. 2015. PMID: 25999402 Free PMC article.

6

Development of a recombinant immunotoxin for the immunotherapy of autoreactive lymphocytes expressing MOG-specific BCRs.

Stepanov A, Belyy A, Kasheverov I, Rybinets A, Dronina M, Dyachenko I, Murashev A, Knorre V, Sakharov D, Ponomarenko N, Tsetlin V, Tonevitsky A, Deyev S, Belogurov A Jr, Gabibov A. Stepanov A, et al. Biotechnol Lett. 2016 Jul;38(7):1173-80. doi: 10.1007/s10529-016-2092-5. Epub 2016 Apr 21. Biotechnol Lett. 2016. PMID: 27099070

7

Using Tiletamine-Zolazepam-Xylazine Anesthesia Compared to CO₂-inhalation for Terminal Clinical Chemistry, Hematology, and Coagulation Analysis in Mice.

Khokhlova ON, Tukhovskaya EA, Kravchenko IN, Sadovnikova ES, Pakhomova IA, Kalabina EA, Lobanov AV, Shaykhutdinova ER, Ismailova AM, Murashev AN. Khokhlova ON, et al. Among authors: murashev an. J Pharmacol Toxicol Methods. 2017 Mar-Apr;84:11-19. doi: 10.1016/j.vascn.2016.10.005. Epub 2016 Oct 20. J Pharmacol Toxicol Methods. 2017. PMID: 27773843

8

Efficacy of Synthetic Peptide Corresponding to the ACTH-Like Sequence of Human Immunoglobulin G1 in Experimental Autoimmune Encephalomyelitis.

Turobov VI, Danilkovich AV, Shevelev AB, Biryukova YK, Pozdniakova NV, Azev VN, Murashev AN, Lipkin VM, Udovichenko IP. Turobov VI, et al. Among authors: murashev an. Front Pharmacol. 2018 Feb 23;9:113. doi: 10.3389/fphar.2018.00113. eCollection 2018. Front Pharmacol. 2018. PMID: 29527165 Free PMC article.

9

Immunosuppressant Peptide Abu-TGIRIS-Abu-NH₂ and its Application for Treatment of Multiple Sclerosis.

Turobov VI, Azev VN, Shevelev AB, Pozdniakova NV, Biryukova YK, Murashev AN, Lipkin VM, Udovichenko IP. Turobov VI, et al. Among authors: murashev an. Bionanoscience. 2018;8(1):484-489. doi: 10.1007/s12668-018-0513-8. Epub 2018 Mar 2. Bionanoscience. 2018. PMID: 29600159 Free PMC article.

10

First-In-Human Trials of GamTBvac, a Recombinant Subunit Tuberculosis Vaccine Candidate: Safety and Immunogenicity Assessment.

Vasina DV, Kleymenov DA, Manuylov VA, Mazunina EP, Koptev EY, Tukhovskaya EA, Murashev AN, Gintsburg AL, Gushchin VA, Tkachuk AP. Vasina DV, et al. Among authors: murashev an. Vaccines (Basel). 2019 Nov 1;7(4):166. doi: 10.3390/vaccines7040166. Vaccines (Basel). 2019. PMID: 31683812 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page